EUVIMEDEUVIMED entdecken
Crossref

Covalent Modifier Discovery Using Hydrogen/Deuterium Exchange–Mass Spectrometry

Hiroyuki Kojima, Ryota Yanagi, Eri Higuchi, Mami Yoshizawa, Tomoyuki Shimodaira, Misaki Kumagai, Tatsuhiro Kyoya, Miyu Sekine, Daichi Egawa, Nami Ohashi, Hiroaki Ishida iD, Keiko Yamamoto iD und 1 weitere

Journal of Medicinal Chemistry · 2023

DOI: 10.1021/acs.jmedchem.2c01986 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Hiroyuki Kojima und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Drug Design and Medicinal Chemistry, Showa Pharmaceutical University, 3-3165 Higashi-Tamagawagakuen, Machida, Tokyo 194-8543, Japan. Hauptthemen laut MEDLINE: Hydrogen Deuterium Exchange-Mass Spectrometry, PPAR gamma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Covalent ligands are generally filtered out of chemical libraries used for high-throughput screening, because electrophilic functional groups are considered to be pan-assay interference compounds (PAINS). Therefore, screening strategies that can distinguish true covalent ligands from PAINS are required. Hydrogen/deuterium-exchange mass spectrometry (HDX-MS) is a powerful tool for evaluating protein stability. Here, we report a covalent modifier screening approach using HDX-MS. In this study, HDX-MS was used to classify peroxisome proliferator-activated receptor γ (PPARγ) and vitamin D receptor ligands. HDX-MS could discriminate the strength of ligand-protein interactions. Our HDX-MS screening method identified LT175 and nTZDpa, which can bind concurrently to the PPARγ ligand-binding domain (PPARγ-LBD) with synergistic activation. Furthermore, iodoacetic acid was identified as a novel covalent modifier that stabilizes the PPARγ-LBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydrogen Deuterium Exchange-Mass SpectrometryPPAR gammaDeuteriumLigandsMass SpectrometryDeuterium Exchange Measurement

Substanzen

DeuteriumLigandsPPAR gamma

Autor:innen und Institutionen

  • Laboratory of Drug Design and Medicinal Chemistry, Showa Pharmaceutical University, 3-3165 Higashi-Tamagawagakuen, Machida, Tokyo 194-8543, Japan.

ORCID-Profile: Hiroaki Ishida, Keiko Yamamoto, Toshimasa Itoh

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology
  • Japan Society for the Promotion of Science

Zitieren

APA

Kojima, H., Yanagi, R., Higuchi, E., Yoshizawa, M., Shimodaira, T., Kumagai, M., Kyoya, T., Sekine, M., Egawa, D., Ohashi, N., Ishida, H., Yamamoto, K., & Itoh, T. (2023). Covalent Modifier Discovery Using Hydrogen/Deuterium Exchange–Mass Spectrometry. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.2c01986

Vancouver

Kojima H, Yanagi R, Higuchi E, Yoshizawa M, Shimodaira T, Kumagai M, et al. Covalent Modifier Discovery Using Hydrogen/Deuterium Exchange–Mass Spectrometry. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.2c01986

BibTeX
@article{Kojima2023,
  author = {Kojima, Hiroyuki and Yanagi, Ryota and Higuchi, Eri and Yoshizawa, Mami and Shimodaira, Tomoyuki and Kumagai, Misaki and Kyoya, Tatsuhiro and Sekine, Miyu and Egawa, Daichi and Ohashi, Nami and Ishida, Hiroaki and Yamamoto, Keiko and Itoh, Toshimasa},
  title = {Covalent Modifier Discovery Using Hydrogen/Deuterium Exchange–Mass Spectrometry},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  doi = {10.1021/acs.jmedchem.2c01986}
}
Kostenlos starten →